Showing results (201-210 of 216) with videos related to
Sort By:
Pageof 22
Chemmedchem|December 7, 2020
A Quick Route to Multiple Highly Potent SARS-CoV-2 Main Protease Inhibitors*Kai S Yang, Xinyu R Ma, Yuying Ma, et al.Biorxiv : the Preprint Server for Biology|August 9, 2020
A Speedy Route to Multiple Highly Potent SARS-CoV-2 Main Protease InhibitorsKai S Yang, Xinyu R Ma, Yuying Ma, et al.Journal of Medicinal Chemistry|August 4, 2006
Synthesis, crystal structure, structure-activity relationships, and antiviral activity of a potent SARS coronavirus 3CL protease inhibitorSyaulan Yang, Shu-Jen Chen, Min-Feng Hsu, et al.Journal of Medicinal Chemistry|July 21, 2021
Self-Masked Aldehyde Inhibitors: A Novel Strategy for Inhibiting Cysteine ProteasesLinfeng Li, Bala C Chenna, Kai S Yang, et al.Proceedings of the National Academy of Sciences of the United States of America|February 5, 2025
Rapid restoration of potent neutralization activity against the latest Omicron variant JN.1 via AI rational design and antibody engineeringYunji Liao, Hang Ma, Zhenyu Wang, et al.BMJ (Clinical Research Ed.)|October 15, 2021
Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trialMichelle Sholzberg, Grace H Tang, Hassan Rahhal, et al.Plos One|June 23, 2021
The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibodyConrad E Z Chan, Shirley G K Seah, De Hoe Chye, et al.Medrxiv : the Preprint Server for Health Sciences|July 16, 2021
Heparin for Moderately Ill Patients with Covid-19Michelle Sholzberg, Grace H Tang, Hassan Rahhal, et al.Blood Advances|June 24, 2022
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis for patients with COVID-19: March 2022 update on the use of anticoagulation in critically ill patientsAdam Cuker, Eric K Tseng, Holger J Schünemann, et al.Blood Advances|February 9, 2021
American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19Adam Cuker, Eric K Tseng, Robby Nieuwlaat, et al.Pageof 22